STAT

OCTOBER 10, 2024

The kickback case began four years ago when the Department of Justice accused Teva of using the foundations to ensure that, from 2006 through 2017, Medicare patients did not have to make a copayment or deductible for the Copaxone multiple sclerosis drug. At the same time, Teva steadily raised the price of its drug by thousands of dollars.

Pharmaceutical Companies 124

Pharmaceutical Companies Pharmaceutical Companies 124

Pharmacy Times

APRIL 11, 2023

State-level respiratory syncytial virus hospitalization rates for 2022 could be the highest seen since 2006, analysis published in Frontiers in Pediatrics indicate.

Hospitals 73

Hospitals 73

STAT

MARCH 23, 2023

This is a significant increase from the 2021 estimate of 1 in 44 , which was a big jump from 1 in 110 in 2006. In a pair of new reports — one focused on 8-year-olds and one on 4-year-olds — the CDC found that 1 out of every 36 children has autism. This increase may sound scary. There is no “epidemic of autism.”

145

145

STAT

MARCH 24, 2024

By the time I wrote my book , “When Illness Goes Public: Celebrity Patients and How We Look at Medicine” in 2006, there were hundreds of stories of famous patients I could have told. But things began to change in the early 20th century.

Chemotherapy 130

Chemotherapy 130

STAT

APRIL 18, 2024

An ongoing investigation into data integrity at Dana-Farber Cancer Institute has resulted in a string of retractions, the latest of which is a 2006 Science paper co-authored by institute president and CEO Laurie Glimcher.

144

144

Fierce Healthcare

SEPTEMBER 1, 2023

Much of the growth experienced by Medicare Advantage over the last two decades can be attri | Beneficiaries switching from fee-for-service Medicare to Medicare Advantage more than tri-pled between 2006 and 2022. Conversely, switching from MA to traditional Medicare decreased.

76

76

STAT

NOVEMBER 14, 2023

Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period. ” A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Continue to STAT+ to read the full story…

145

145

Blog: Ask a Student Pharmacist

OCTOBER 4, 2023

Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

52

52

STAT

FEBRUARY 1, 2023

billion fundraising in 2006, according to data from PitchBook. The firm, Patient Square Capital, closed on $3.9 billion for its fund Wednesday. That makes it the largest inaugural fund for a new U.S.-based based private equity firm. The previous record was set by Centerbridge Partners’ $3.2

98

98

STAT

NOVEMBER 23, 2022

Since 2006, physician and researcher Emily Wang has been working to integrate the two. has two separate health care systems: one for people who aren’t incarcerated, and one for people behind bars. “There’s really no glue, no connection between these health care systems,” Wang said.

98

98

STAT

NOVEMBER 27, 2023

The problem has persisted, even after the European Union in 2006 banned the use of antibiotics for promoting growth, since bulking up the animals makes them better suited for increased production.

110

110

STAT

OCTOBER 2, 2023

The Pandemic All-Hazards Preparedness Act was a Bush administration priority that Congress passed in 2006 to help the government respond to nuclear and biological attacks and naturally occurring threats, such as pandemics. That temporary funding measure also extended a few programs that are part of the Pandemic All-Hazards Preparedness Act.

133

133

PioneerRx

AUGUST 11, 2022

Pleio began in 2006 when a group of partners sat around a kitchen table and shared their concerns for their friends and… Change always begins with a conversation.

52

52

PioneerRx

AUGUST 11, 2022

Pleio began in 2006 when a group of partners sat around a kitchen table and shared their concerns for their friends and… Change always begins with a conversation.

52

52

STAT

NOVEMBER 18, 2022

The problem has persisted, even after the European Union in 2006 banned the use of antibiotics for promoting growth, since bulking up the animals makes them better suited for increased production. Continue to STAT+ to read the full story…

98

98

STAT

JULY 7, 2023

The Pandemic All-Hazards Preparedness Act was enacted in 2006 to help the government respond to nuclear and biological weapons, naturally occurring threats like avian influenza, and natural disasters.

Packaging 98

Packaging 98

PQA

FEBRUARY 16, 2024

Kelman was a trusted advisor to PQA since its establishment in 2006. Kelman served on the PQA Board of Directors for 10 years and most recently served on the board as a CMS Special Advisor. He was kind, generous and thoughtful in his support of PQA and its mission.Kelman joined CMS in 2005 and helped implement the Part D program.

52

52

Blog: Ask a Student Pharmacist

MARCH 6, 2024

Diane Hutchinson, MLS(ASCP)cm, SHcm eomizowh Wed, 03/06/2024 - 15:36 Bachelor of Science Degree in Medical Technology, December 2006 Coursework included Biochemistry, Organic Chemistry, Physical Chemistry, Calculus, Physiology, Genetics, Statistics, Physics, Microbiology, Biomaterials, Thermodynamics, and Medical Technology coursework.

52

52

STAT

JULY 11, 2023

In 2006, when many Americans had barely heard the word “coronavirus,” Congress passed the Pandemic and All Hazards Preparedness Act (PAHPA), a landmark, bipartisan legislative framework that has successfully steered our nation’s biosecurity policy ever since.

Vaccines 75

Vaccines 75

European Pharmaceutical Review

AUGUST 16, 2023

Sandoz launched its first biosimilar – somatropin (Omnitrope) – in Europe in 2006. The company, a division of Novartis, currently has a portfolio of eight marketed biosimilars, with a further 24 in various development stages.

98

98

Pharmaceutical Technology

JUNE 7, 2023

Since 2006, IFC has repeatedly provided support to Fosun Pharma, which is committed to ensuring the continuous accessibility and affordability of pharmaceutical products and improving the resilience of healthcare supply chains in the region.”

96

96

STAT

OCTOBER 28, 2024

At issue is a medicine called posaconazole that was approved in 2006 in the U.S. The information, however, is not in the label because the drug — originally manufactured by Merck — was never fully tested in this population. And the company has refused to update the language. but is now also sold by generic companies.

Labelling 102

Labelling Chemotherapy 102

European Pharmaceutical Review

JUNE 24, 2022

Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance). Amsterdam: Gupta Strategists; 2019.

Compounding 105

Compounding Packaging Dosage Communication 105

Pharma Times

NOVEMBER 4, 2021

The research paper, published in the Lancet and funded by Cancer Research UK, considered all cervical cancers diagnosed in England among women aged 20-64 between January 2006 and June 2019

Vaccines 35

Vaccines 35

STAT

SEPTEMBER 22, 2023

Krystal, who worked for both Yale and the VA at the time, and his co-inventors applied for patents with VA funding starting in 2006 for a ketamine nasal spray to treat depression and suicidal ideation. Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions.

Department of Veterans Affairs 106

Department of Veterans Affairs Compounding Pharmacies Compounding Chemotherapy 106

Pharmaceutical Technology

MAY 10, 2023

The CDC had applied for patents back in 2006, and was later granted four in 2015. The government had called for Gilead to “respect the US patent system” and the taxpayer-funded research undertaken by the CDC, per the statement. The November 2019 lawsuit marked a further escalation in an existing dispute.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

European Pharmaceutical Review

NOVEMBER 16, 2023

To support biosimilar adoption and expand access for patients in Europe, measures must be taken to reduce the cost of developing biosimilars” Since their introduction in 2006, biosimilars have generated more than €30 billion in cumulative savings for European healthcare systems as of 2022, an IQVIA report from last year highlighted.

110

110

Hospital Pharmacy Europe

MAY 18, 2023

A study of GP research database between 2006 and 2021 found one in three of those with rheumatoid arthritis or fibromyalgia had received long-term prescriptions for the potentially addictive drugs to manage their pain. in 2020.

Hospitals 52

Hospitals 52

IDStewardship

JUNE 18, 2023

It was the dawn of the online streaming era, and platforms such as YouTube, acquired by Google only a year earlier (2006), were brand new. When people thought about online web streaming in those days, they tended to think about cute cat videos and biting toddlers.

Hospitals 217

Hospitals 217

The FDA Law Blog

NOVEMBER 11, 2024

As those of us of a certain age remember, prior to 2005/2006, pseudoephedrine was the decongestant of choice for OTC multi-symptom cold medicine. Missing from FDA’s POA, generally, or the Background, Regulatory History for Oral Phenylephrine, is any discussion of why PE is so widely used. a); OTC Monograph M012: § M012.20.

FDA 109

FDA Documentation Dosage 109

PQA

MAY 10, 2023

This is the first major update to PQA’s look since the organization was established in 2006. They represent how our diverse members come together through PQA to build consensus. And everything originates from or leads to the “Q” in PQA – quality.

Communication 52

Communication 52

Druggist

APRIL 20, 2021

It is recommended to use montelukast as a secondary option in treating allergic rhinitis, preferably in combination with an antihistamine (Grainger & Drake-Lee, 2006). Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P (2006). 2006 Nov;97(5):664-71. Grainger J, Drake-Lee A (2006). 2006 Oct;31(5):360-7.

Compounding 52

Compounding 52

The Happy PharmD

SEPTEMBER 17, 2024

Websites like Indeed list thousands of job postings monthly, with sign-on bonuses becoming more common — a trend not seen since pre-2006. Despite these challenges, the demand for grocery store pharmacists remains robust. Looking forward, innovation in grocery store pharmacies shows promise.

Grocery Stores 52

Grocery Stores Independent Pharmacies Community Pharmacies Vaccines 52

pharmaphorum

DECEMBER 12, 2022

” Anderson joined Roche’s Genentech division in 2006 as head of its immunology and ophthalmology business unit, after nine years at Biogen that culminated in a two-year stint as head of neurology. “He has been instrumental in shaping Roche’s transformation and I wish him all the best for the future.”

95

95

Roots Analysis

FEBRUARY 26, 2024

In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry.

Medication Delivery 52

Medication Delivery Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmacy Friday Pearls

APRIL 22, 2022

Zuckerbraun et al, 2006 Retrospective N=101 Etomidate for RSI in general population There was no relationship between seizures after etomidate administration and prior seizure history (p = 0.25). 2006 Jun;13(6):602-9. Micromedex [Electronic version].Greenwood Greenwood Village, CO: Truven Health Analytics. 2018 Oct;61:170-176.

Documentation 40

Documentation 40

pharmaphorum

SEPTEMBER 30, 2022

First launched in 2006, sales of Januvia and its line extensions have remained reasonably strong despite increasing pressure in the type 2 diabetes market and price pressures, particularly in international markets. billion in the first half of 2022.

Vaccines 59

Vaccines FDA 59